Quantcast
Last updated on April 23, 2014 at 11:04 EDT

Latest Generalized anxiety disorder Stories

2008-12-25 09:19:25

Anxiety disorders in children and adolescents should be recognized and treated to prevent educational underachievement and adult substance abuse, anxiety disorders and depression, says a nationally recognized child psychiatrist from UT Southwestern Medical Center.In an editorial appearing in the Dec. 25 issue of New England Journal of Medicine, Dr. Graham Emslie, professor of psychiatry and pediatrics at UT Southwestern, urges awareness that children need to be treated for anxiety disorders...

2008-12-11 08:30:00

Mental Health America Offers Tips on Reducing Anxiety over Economic Bad News ALEXANDRIA, Va., Dec. 11 /PRNewswire-USNewswire/ -- Record numbers of homes are in foreclosure, stock prices are hitting all-time lows, savings are rapidly dwindling, and the cost of living is rising. Are American families feeling the strain? The answer is yes according to the latest AP/Yahoo poll. The number of people who say they are personally happy is at 59 percent, down from 70 percent in September. A...

2008-12-04 22:47:22

Children with lower IQs show an increased risk of developing psychiatric disorders such as schizophrenia or depression, U.S. researchers said. Lead author Karestan Koenen of the Harvard School of Public Health said study participants were members of the Dunedin Multidisciplinary Health and Development Study, involving children born in 1972-1973 in Dunedin, New Zealand. At the initial assessment at age 3, the study had 1,037 children. The participants were also interviewed and tested on their...

d18a1f8412115fae762190675047a5a31
2008-10-31 08:30:00

The most common psychiatric illnesses in children are successfully treated with a popular antidepressant and months of psychotherapy, according to researchers. The study found the drug sertraline, available as a generic and under the brand name Zoloft, worked best when combined with therapy. Dr. John Walkup, lead author of the government-funded research, said each method alone also had big benefits. The study, published online in the New England Journal of Medicine, was scheduled for...

2008-10-15 12:00:34

WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- The international financial and home foreclosure crisis has not only made an impact on the wallets of families across the country it has also made a serious impact on their mental health and wellbeing. In order to address the growing problem Men's Health Network is making available Your Head: An Owners Manual; Understanding and Overcoming Depression, Anxiety and Stress. Written by Armin Brott and a Medical Advisory Board, the manual addresses...

2008-10-06 15:00:41

BOSTON, Oct. 6 /PRNewswire-USNewswire/ -- Military life can present challenges to Service members and their families that are unique and difficult. Some are manageable, some are not. In some instances matters get worse and one problem can trigger other more serious issues. At such times it is wise to check things out to see what is really happening. (Photo: http://www.newscom.com/cgi-bin/prnh/20081006/DC37122 ) To help those who may be struggling, military installations worldwide will...

2008-08-22 09:01:11

Eli Lilly and Company and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta for the treatment of generalized anxiety disorder. This approval - the fourth for duloxetine in Europe - was issued in July 2008, following an initial positive opinion issued by the European Medicines Agency's Committee for Medicinal Products for Human Use in June 2008. The approval is based upon the results of five clinical studies of generalized anxiety disorder...

2008-06-27 12:02:19

Eli Lilly and Co and Boehringer Ingelheim have announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion supporting the approval of Cymbalta for the treatment of generalized anxiety disorder. The positive opinion is based upon the results of five clinical studies - four double-blind placebo-controlled studies and a relapse prevention study - involving more than 2,000 non-depressed adults with generalized anxiety...

2008-06-27 03:00:35

INDIANAPOLIS, June 27 /PRNewswire-FirstCall/ -- Eli Lilly and Co and Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion supporting the approval of Cymbalta(R) (duloxetine hydrochloride) for the treatment of Generalised Anxiety Disorder (GAD). The positive opinion is based upon the results of five clinical studies -- four double-blind placebo-controlled studies and a...

2008-06-18 09:01:19

WALTHAM, Mass., June 18 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Lexapro is the leading single agent used in anxiety therapy with 11.7 percent and 14.9 percent of first- and second-line patient share, respectively. According to surveyed psychiatrists and primary care physicians (PCPs), Lexapro is distinguished by its superior safety and tolerability profile; physicians specifically...


Latest Generalized anxiety disorder Reference Libraries

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

More Articles (1 articles) »